HomeTechnologiesArtificial Intelligence

Artificial Intelligence

Enter your email above to receive messages about offerings by Informa, its brands, affiliates and/or third-party partners, consistent with Informa's Privacy Statement.

Leave this field blank

Can Transparent AI Analysis Boost IVF Outcomes?

May 23, 2022

Fairtility just raised $15 million in series A funding to support its transparent AI analysis technology for better in vitro fertilization (IVF) outcomes.

What FDA’s New Machine Learning Guiding Principles Really Mean

May 23, 2022

FDA recently published a set of 10 guiding principles to inform the development of Good Machine Learning Practice.

Paige Wins CE-IVD & UKCA Marks for AI that Detects 4 Prostate Cancer Biomarkers

May 18, 2022

The biomarker suite has the potential to expand the utility of AI to analyze tissues prepared with the most frequently used stain in histology.

Zimmer Biomet Beats Analyst Expectations in Q1

May 04, 2022

Strong procedure volume recovery drove underlying growth, but headwinds cloud Zimmer Biomet's forecast.

Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

Apr 27, 2022

This will be the third clinical-stage program in Xbiome’s growing pipeline supported by AI and biotechnology platforms.

Digital Rehab Tech Startup Raises $11M

Apr 20, 2022

In just over five years GripAble has rocketed from being a laboratory design concept to a therapeutic used in hundreds of centers globally.

Ultrasound AI Aims to Save Infants with AI-powered Detection Software

Apr 20, 2022

The company's software platform has not yet received FDA clearance.

AI-Powered Cancer Monitoring Test Launched Across Europe

Apr 14, 2022

C2i Genomics launches minimal residual disease test across Europe after clearing regulatory hurdles in the EU, UK, and Switzerland.

Unlocking Precision Medicine, Drug Discovery, and More with Next-Gen Healthcare

Apr 07, 2022

Artificial intelligence is becoming a core component in all aspects of diagnostics, drug discovery, and more, explains Nandha Balasubramaniam, Head of Digitalomics at Oracle Heath, who will be speaking at MD&M West.

Eko Launches Redesigned App to Screen for Heart Disease

Mar 22, 2022

FDA’s clearances are for artificial intelligence (AI) algorithms that detect leading indicators of heart disease.

Artificial Intelligence

Keep You Informed